Mutual fund · AMFI 120782
UTI Healthcare Fund
NAV ₹398.10 · 17 Nov 2026
UTI Healthcare Fund is a sectoral-pharma mutual fund run by UTI. Its NAV was ₹398.10 on 17 Nov 2026, up 21.2% over one year and 23.0% a year over three years. The direct plan's total expense ratio was 1.31% in the latest AMFI data. The top 10 holdings made up 46.6% of the portfolio in October 2026.
Returns from NAV
One year and shorter are absolute; three and five years are annualised. Based on NAV, so dividend payouts are not added back. Past performance does not guarantee future results.
Risk · last 3.0 years
How bumpy the ride has been
Worked out from weekly NAVs. The largest fall ran from 02 Jan 2025 to 03 Mar 2025. Sharpe and Sortino use a fixed 6.5% a year risk-free rate for comparison. Past figures are not a guide to future returns.
What the fund charges
From AMFI's expense ratio data, updated 19 Nov 2026. The regular plan charges more; see the fund's factsheet.
Portfolio · October 2026
Top holdings (46 in total)
| Company | % of fund | vs last month |
|---|---|---|
| EQ - SUN PHARMACEUTICALS INDUSTRIES | -0.18 | |
| EQ - DIVIS LABORATORIES LTD. | +0.31 | |
| EQ - DR REDDYS LABORATORIES LTD. | +0.54 | |
| EQ - AJANTA PHARMA LTD. | -0.52 | |
| EQ - MAX HEALTHCARE INSTITUTE LTD | +1.4 | |
| EQ - GLAND PHARMA LTD. | -0.17 | |
| EQ - APOLLO HOSPITALS ENTERPRISE LT | +0.8 | |
| EQ - ALKEM LABORATORIES LTD | -0.04 | |
| EQ - LUPIN LTD. | +0.76 | |
| EQ- GLOBAL HEALTH LTD. | +0.41 | |
| EQ - COHANCE LIFESCIENCES LIMITED | 0.0 | |
| EQ - CAPLIN POINT LABORATORIES LTD | -0.34 | |
| EQ - IPCA LABORATORIES LTD. | -0.27 | |
| EQ- JUPITER LIFE LINE HOSPITALS LTD | +0.15 | |
| EQ - MARKSANS PHARMA LTD. | -0.11 |
The top 10 make up 46.6% of the fund. Source: the fund house's monthly portfolio disclosure.
Since September 2026
What changed
New holdings
- EQ - SAHAJANAND MEDICAL TECHNOLOGIES LIMITED1.44%
- EQ - NATCO PHARMA LTD.0.59%
Biggest changes in weight
- EQ - MAX HEALTHCARE INSTITUTE LTD2.8% to 4.2%
By sector
Where the money is
Pharmaceuticals & Biotechnology68.7%
Healthcare Services25.8%
Not Applicable1.4%
Healthcare Equipment & Supplies1.1%
Chemicals & Petrochemicals1.0%
Equity: Sectoral-Pharma
Other funds in this category
Six large funds in the same category, listed for comparison only.
Learn more
Mutual fund guides
Your mutual funds
Review your own mutual fund portfolio
Upload or fetch your holdings and see each fund's returns, cost and overlap against benchmarks, as facts. Review my mutual funds
Questions
About UTI Healthcare Fund
What is the NAV of UTI Healthcare Fund?
The net asset value was Rs 398.10 on 17 November 2026.
What is the expense ratio of UTI Healthcare Fund?
The direct plan's total expense ratio was 1.31% in the latest AMFI data, about Rs 13,100 a year on Rs 10 lakh invested.
What is the one-year return of UTI Healthcare Fund?
The NAV changed by 21.2% over the last year; past returns do not indicate future returns.
Data: AMFI NAVs and expense ratios and the fund house's monthly portfolio disclosures. This page states facts and is not a recommendation to buy or sell. Mutual fund investments are subject to market risks; read all scheme-related documents carefully. Past performance does not guarantee future results.